Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
Spain flag Spain · Delayed Price · Currency is EUR
59.05
+0.10 (0.17%)
May 18, 2026, 4:24 PM CET

BME:ROVI Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
741.09743.48763.75829.51817.7648.68
Revenue Growth (YoY)
-3.44%-2.65%-7.93%1.44%26.06%54.46%
Cost of Revenue
267.01271.9296.04346.17305.27268.84
Gross Profit
474.08471.59467.71483.34512.43379.84
Selling, General & Admin
163.42160.47158.26147.02129.99103.36
Other Operating Expenses
119.23107.6102.7392.52105.8474.96
Operating Expenses
313.91298.45289.01263.87258.69199.68
Operating Income
160.17173.14178.71219.47253.74180.15
Interest Expense
-2.72-2.56-1.99-0.95-0.85-0.91
Interest & Investment Income
0.510.510.030.010.010.07
Earnings From Equity Investments
0.180.06-0.14-0.130.20.18
Currency Exchange Gain (Loss)
0.16-0.210.3-0.09-0.82-0.18
Other Non Operating Income (Expenses)
14.1412.330.792.093.933.4
EBT Excluding Unusual Items
172.43183.26177.69220.41256.21182.72
Gain (Loss) on Sale of Investments
----1.76-
Asset Writedown
0.28----0-0.1
Pretax Income
172.7183.26177.69220.41257.97182.63
Income Tax Expense
40.9742.940.8150.1158.329.55
Earnings From Continuing Operations
131.74140.36136.88170.3199.67153.08
Minority Interest in Earnings
0.080.080.010.040-
Net Income
131.82140.44136.88170.34199.67153.08
Net Income to Common
131.82140.44136.88170.34199.67153.08
Net Income Growth
-5.86%2.60%-19.64%-14.69%30.44%150.71%
Shares Outstanding (Basic)
515151535355
Shares Outstanding (Diluted)
515151535355
Shares Change (YoY)
--0.13%-3.73%-0.51%-3.50%0.03%
EPS (Basic)
2.582.752.673.203.732.76
EPS (Diluted)
2.582.752.673.203.732.76
EPS Growth
-2.73%-16.53%-14.25%35.31%150.36%
Free Cash Flow
116.54121.8779.1659.45186.88109.22
Free Cash Flow Per Share
2.282.381.551.123.501.97
Dividend Per Share
--0.9351.1041.2940.956
Dividend Growth
---15.28%-14.69%35.39%150.68%
Gross Margin
63.97%63.43%61.24%58.27%62.67%58.55%
Operating Margin
21.61%23.29%23.40%26.46%31.03%27.77%
Profit Margin
17.79%18.89%17.92%20.53%24.42%23.60%
Free Cash Flow Margin
15.73%16.39%10.37%7.17%22.86%16.84%
EBITDA
183.45195.54199.62238.02271.33196.56
EBITDA Margin
24.75%26.30%26.14%28.69%33.18%30.30%
D&A For EBITDA
23.2822.3920.9118.5417.5916.41
EBIT
160.17173.14178.71219.47253.74180.15
EBIT Margin
21.61%23.29%23.40%26.46%31.03%27.77%
Effective Tax Rate
23.72%23.41%22.97%22.73%22.60%16.18%
Advertising Expenses
-1821.7421.7519.9912.71
Source: S&P Global Market Intelligence. Standard template. Financial Sources.